PRECISION BIOSCIENCES INC (DTIL) › Operating IncomePRECISION BIOSCIENCES INC (DTIL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$47.91M2019: -$87.20M2020: -$109.83M2021: -$39.38M2022: -$62.31M2023: -$43.74M2024: -$26.16M2025: -$52.15M-$52.15M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$52.15M-99.3%2024-$26.16M+40.2%2023-$43.74M+29.8%2022-$62.31M-58.2%2021-$39.38M+64.1%2020-$109.83M-25.9%2019-$87.20M-82.0%2018-$47.91M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share